Floatz logo

21 assets in Atrial Fibrillation

Therapeutic assets addressing Atrial Fibrillation, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Edoxaban
Atrial Fibrillation
National Taiwan University HospitalP4A (83)
Dabigatran
Atrial Fibrillation
PfizerP4BBB (79)
Rivaroxaban
Atrial Fibrillation
VA Office of Research and DevelopmentP4BBB (79)
Apixaban
Atrial Fibrillation
Regeneron PharmaceuticalsP4BBB (77)
Warfarin
Atrial Fibrillation
PfizerP4BBB (77)
Aspirin
Atrial Fibrillation
Yonsei UniversityP4BBB (75)
Clopidogrel
Atrial Fibrillation
Yonsei UniversityP4BB (67)
Semaglutide
Atrial Fibrillation
Ali AminianP4BB (67)
Tirzepatide
Atrial Fibrillation
Ali AminianP4BB (67)
Amrecibart
Atrial Fibrillation
Regeneron PharmaceuticalsP3BB (66)
Bay 59-7939
Atrial Fibrillation
BayerP3BB (66)
Cenvacibart
Atrial Fibrillation
Regeneron PharmaceuticalsP3BB (66)
Empagliflozin
Atrial Fibrillation
Ali AminianP4BB (66)
Liraglutide
Atrial Fibrillation
Ali AminianP4B (62)
Asundexian
Atrial Fibrillation
BayerP3B (60)
Abelacimab
Atrial Fibrillation
Anthos Therapeutics, Inc.P2CCC (53)
Human Relaxin 1
Atrial Fibrillation
Deeptankar DeMazumderP1/2CCC (48)
Dexmedetomidine
Atrial Fibrillation
Beijing Anzhen HospitalN/AD (30)
Fentanyl
Atrial Fibrillation
Beijing Anzhen HospitalN/AD (30)
Flurbiprofen Axetil
Atrial Fibrillation
Beijing Anzhen HospitalN/AD (30)
Midazolam
Atrial Fibrillation
Beijing Anzhen HospitalN/AD (30)